Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Long-Term Debt Repayments (2022 - 2024)

Coeptis Therapeutics Holdings (COEP) has 3 years of Long-Term Debt Repayments data on record, last reported at $63469.0 in Q4 2024.

  • For Q4 2024, Long-Term Debt Repayments fell 81.87% year-over-year to $63469.0; the TTM value through Dec 2024 reached $700970.0, down 17.53%, while the annual FY2024 figure was $650969.0, 46.86% down from the prior year.
  • Long-Term Debt Repayments reached $63469.0 in Q4 2024 per COEP's latest filing, down from $287500.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $500000.0 in Q4 2022 and bottomed at $50000.0 in Q3 2022.
  • Average Long-Term Debt Repayments over 3 years is $250161.7, with a median of $268750.0 recorded in 2022.
  • Peak YoY movement for Long-Term Debt Repayments: decreased 30.0% in 2023, then tumbled 81.87% in 2024.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $500000.0 in 2022, then fell by 30.0% to $350001.0 in 2023, then crashed by 81.87% to $63469.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $63469.0 in Q4 2024, $287500.0 in Q1 2024, and $350001.0 in Q4 2023.